ConductScience.org, home

Comparison · NCT04445792-sae

Immediate Pharmacogenetics (PGx) Guided Therapy vs Delayed Pharmacogenetics (PGx) Testing: serious adverse events

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Immediate Pharmacogenetics (PGx) Guided Therapy vs Delayed Pharmacogenetics (PGx) Testing: serious adverse events. Trial comparisons, record NCT04445792-sae. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT04445792-sae

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 1000.0015wilson
Risk in group 2000.0015wilson
Risk difference, group 1 minus group 20-0.00150.0015newcombe hybrid score
Risk ratio, group 1 over group 2loga group has no participants with the outcome
Odds ratio, group 1 over group 2loga cell of the two-by-two table is zero
Number needed to harmfrom the risk difference intervalthe two groups' risks are equal

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Immediate Pharmacogenetics (PGx) Guided Therapy
Acute Pain Trial: Immediate pharmacogenetic testing and genotype-guided post-surgical opioid therapy (Intervention arm).~Chronic Pain Trial: Immediate pharmacogenetic testing and genotype-guided opioid therapy (Intervention arm).~Depression: Immediate pharmacogenetic testing and genotype-guided anti-depressant therapy (Intervention arm).
02,550EG000
Group 2Delayed Pharmacogenetics (PGx) Testing
Acute Pain Trial: Standard care and pharmacogenetic testing after 6 months (Control arm).~Chronic Pain Trial: Standard care with 6-month delayed pharmacogenetic testing (Control arm).~Depression: Standard care with 6-month delayed pharmacogenetic testing (Control arm).
02,550EG001

Harm

What it counts
Total, serious adverse events
Time frame
Approximately 6 months

Source ClinicalTrials.gov

Trial

Title
A Depression and Opioid Pragmatic Trial in Pharmacogenetics (DCRI Coordinating Center)
NCT number
NCT04445792
Phases
NA
Conditions
Depression, Acute Pain, Chronic Pain
Interventions
Pharmacogenetic testing, Clinical decisions support
Lead sponsor
Duke University
Results first posted
2025-01-06

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT04445792-sae